Manchester Academic Health Science Centre achieves national status
The Trust is delighted to announce that the Manchester Academic Health Science Centre (MAHSC) has achieved official national status.
Health Secretary Alan Johnson has revealed the successful Academic Health Science Centres to the public following peer review by an international panel of experts.
MAHSC is a partnership which was launched last year between our Trust and The Christie NHS Foundation Trust, Manchester Mental Health and Social Care Trust, Salford Primary Care Trust, Salford Royal NHS Foundation Trust, University Hospital of South Manchester NHS Foundation Trust and The University of Manchester.
The Manchester Biomedical Research Centre (BRC), based in our Trust, is also one of the important foundations of the Manchester Academic Health Science Centre. The Academic Health Science Centre (AHSC) award will enable it to deliver the benefits which will flow from our BRC to patients faster and more effectively. We look forward to working with Professor Alan North, Director of MAHSC, and his colleagues to fully exploit the benefits of the AHSC award.
Mike Deegan, Chief Executive of the Trust, said: “I am really pleased that Manchester’s excellence in the delivery of top quality research, innovation and education has been properly recognised.
“The MAHSC designation will provide the BRC Partnership with the opportunity to fully integrate our BRC research strengths and our MAHSC Partners combined investments in leading edge technologies from across Greater Manchester to develop really world class research programmes.
“These will be the foundation for the delivery of the best care for our patients and enable us to train future generations of top class clinicians, who will be the clinical leaders of the future.”
MAHSC has now been recognised as having the potential to compete globally with established centres such as those in the United States, Canada, Singapore, Sweden and the Netherlands. The centre will be well-placed to compete on the world stage for talent and funding, drawing in economic benefits for the Northwest and the UK.
The vision for MAHSC focuses on providing improved healthcare locally and more widely. MAHSC will now have an emphasis on world class biomedical and healthcare research and will also co-ordinate teaching and training of healthcare professionals leading to the strategic planning of research-led healthcare provision and management. This will lead to demonstrably improved health and health care adoption of new discoveries and practices both locally and internationally.
The accreditation process for official status has been led by the Department of Health and is seen as a way to secure substantial funding for national leaders in education, research and health provision.
Alan Johnson said: “I congratulate the successful candidates, who have demonstrated their enthusiasm and commitment to the vision of bringing together world-class research, teaching and patient care to improve health in local communities as well as internationally through their global reach. NHS patients will reap the benefits of the work of these new centres.
“In times of economic uncertainty it is even more important that we continue to support this country’s knowledge industries to ensure that we benefit from the competitive edge which they provide.”
Bob Pearson, Medical Director for the Trust, added: “Our hospital is proud to be one of the founding members of the Manchester Academic Health Science Centre. It gives us all a fantastic opportunity to harness the strengths of the MAHSC Partners to develop a superb healthcare environment, within which we can deliver the very best care for our patients.
“I am personally looking forward to bringing together the Trust’s £500 million investment in new hospital facilities, with our national Biomedical Research Centre and now the AHSC to create the very best clinical academic campus.
“I am confident that we now have assembled the very best facilities, clinical leaders and research teams to make our hospitals the place of choice for our patients and also for the staff that we need to recruit in the future to keep delivering the most advanced care; driven forward by our top class clinical research teams.”